CPR Invest - Reactive - A EUR - Acc ISIN : LU1103787690

CPR Invest - Reactive - A EUR - Acc
Asset class: Balanced

YTD
As of 17/11/2026
-0.06%

Risk IndicatorThe level of risk of the fund mainly reflects the risk of the market in which the fund is invested and, as the case may be, the leveraging strategy or inverse performance of the index. The capital initially invested does not benefit from any guarantee. The current level of risk does not indicate the future level of risk and may change over time. The lowest risk level is not equal to a risk-free investment.
1234567
Lower Risk
Higher Risk
The risk indicator assumes you keep the product according to the holding period.

NAV
As of 17/11/2026
€1,348.14

SFDR ClassificationSustainable Finance Disclosure Regulation
Art. 8

Fund AUM
As of 17/11/2026
€58.92M
This international diversified sub-fund aims to outperform its benchmark index over a minimum of 4 years with maximum projected volatility of 15%. The portfolio's equity exposure ranges from 20% to 80% and its interest-rate sensitivity from -2 to +5. The sub-fund is a feeder fund for the French mutual fund CPR Croissance Réactive.

NAVs

NAV from 21/11/2016 to 17/11/2026
Select period
Created with Highcharts 11.4.8CPR Invest - Reactive - A EUR - AccJul '17Jul '18Jul '19Jul '20Jul '21Jul '22Jul '23Jul '24Jul '25Jul '269001K1.1K1.2K1.3K1.4K1.5K

Performance

Change in NAV in base 100
FundCPR Invest - Reactive - A EUR - Acc (24.38% over the period)
Select period
Created with Highcharts 11.4.8CPR Invest - Reactive - A EUR - AccBenchmarkJul '17Jul '18Jul '19Jul '20Jul '21Jul '22Jul '23Jul '24Jul '25Jul '2680100120140160
FundCPR Invest - Reactive - A EUR - Acc (24.38% over the period)
Select period
Created with Highcharts 11.4.8CPR Invest - Reactive - A EUR - AccBenchmarkJul '17Jul '18Jul '19Jul '20Jul '21Jul '22Jul '23Jul '24Jul '25Jul '2680100120140160

Portfolio Analysis

Repartition 10/31/2026
Sector
Weight
AM EURO LIQUIDITY S-T RESP - Z (C)Money Market Investments9.75%
CPR INVEST - CLIMATE BONDS EURO - Z EURInvestment Grade EMU6.55%
AMUNDI EURO LIQUIDITY SELECT - Z (C)Money Market Investments6.18%
AM MSCI WRLD SCREENED UCITS ETF (PAR)Equities World5.46%
abrdn Em Mkt Lcl Ccy Dbt K Acc EURGovies Emerging Global5.41%
CPR ABSOLUTE RETURN BONDS - Z (C)Absolute Return Fixed Income5.35%
Amundi USD Corporate Bond ESG ETF DR CInvestment Grade USA5.18%
CPR INVEST - CREDIXX GLOB HI YIELDHigh Yield World4.72%
ARI - EUROPEAN CREDIT- I2 - CInvestment Grade EMU4.24%
BFT CREDIT OPPORT ISR CLIMAT - I2 (C)Investment Grade Europe3.84%

Management commentary

Effective date: 31/10/2026The month of October was marked by a new surge in energy prices, against a backdrop of persistent geopolitical tensions in the Middle East. Brent crude rose by nearly 14%, while natural gas returned to its highest levels since the end of 2022. This dynamic led to an acceleration in headline inflation in both the eurozone and the United States, without, at this stage, causing a comparable increase in core components. Economic activity remained generally resilient, particularly in the United States, even though the deterioration of the US labor market and the slowdown in European business surveys sent more mixed signals.
 
In this context, the Fed, the ECB, and the Bank of Japan kept their key interest rates unchanged, while maintaining cautious communication in the face of inflationary risks. Bond markets benefited from this monetary pause and a flight to safe-haven assets, resulting in a significant decline in sovereign yields. Conversely, equity markets were shaken at the end of the month by disappointing earnings reports from several major technology companies, which reignited questions about the profitability of massive investments in artificial intelligence. Technology stocks, semiconductors, and emerging markets thus underperformed, while European equities and sectors less exposed to the AI theme proved more resilient.
 
In light of this environment, we maintain a slightly cautious bias on equities. The most concentrated exposures to large US technology stocks, the Nasdaq, and semiconductors have been reduced, as well as certain thematic and emerging market positions. These adjustments aim to limit the sensitivity of allocations to segments with the highest valuation levels and earnings expectations. At the same time, we are favoring broader indices to improve diversification and reduce concentration risk.
From a sector perspective, we are strengthening our preference for healthcare and energy. Healthcare offers more defensive characteristics, better earnings visibility, and relatively limited sensitivity to the economic cycle. Energy, for its part, benefits from rising hydrocarbon prices and serves as a partial hedge against persistent geopolitical and inflationary tensions. Exposure to emerging markets remains more measured, given their sensitivity to the technology sector, the ongoing weakness of Chinese domestic demand, and a still restrictive rate environment.
 
In bond markets, we favor a contained duration, mainly in the five- to seven-year maturities. This positioning allows us to benefit from carry and a potential further easing of yields, while limiting exposure to longer maturities, which are more vulnerable to a renewed rise in inflation expectations. Government bonds also continue to play an important role in diversification and protection in the event of renewed risk aversion in equity markets.
Within credit, the euro investment grade segment remains favored due to the quality of issuers and an always attractive risk-return profile. US high yield also offers an interesting source of carry, but only within a rigorous selection framework, given the level of financing rates and the risks of dispersion among issuers. Finally, emerging market debt in local currencies can provide additional diversification, provided a selective approach is maintained regarding currency, inflation, and monetary policy risks specific to each country.

Characteristics

General data

Inception date
29/08/2014
First Nav Date
18/04/1997
Currency
EUR
Show more
Valuation
Daily
Minimum initial investment
1 10/1000° share(s)/equity
Minimum additional investment
1 10/1000° share(s)/equity

Costs Composition

One-off costs upon entry or exit (Investment EUR 10,000)If you exit after 1 year
Entry costsThis includes distribution costs of 5.00% of amount invested. This is the most you will be charged. The person selling you the product will inform you of the actual charge.Up to €500.00
Exit costsWe do not charge an exit fee for this product, but the person selling you the product may do so.€0.00
Ongoing costs taken each year (Investment EUR 10,000)
Management fees and other administrative or operating costs2.30% of the value of your investment per year. This percentage is based on actual costs over the last year.€218.88
Transaction costsWe do not charge a transaction fee for this product€0.00
Incidental costs taken under specific conditions (Investment EUR 10,000)
Performance fees

20.00% annual outperformance of the reference asset 100% ESTR CAPITALISE (OIS). The calculation applies on each Net Asset Value calculation date in accordance with the terms described in the prospectus. Past underperformances over the last 5 years should be clawed back before any new accrual of performance fee.The actual amount will vary depending on how well your investment performs. The aggregated cost estimation above includes the average over the last 5 years.

The performance fee is paid even if the performance of the share over the performance observation period is negative, while remaining higher than the performance of the Reference Asset.

€0.00

Codification

ISIN code
LU1103787690
Bloomberg code
CPRRCAC LX
Reuters code
LP68277370

Investment Objective

This international diversified sub-fund aims to outperform its benchmark index over a minimum of 4 years with maximum projected volatility of 15%. The portfolio's equity exposure ranges from 20% to 80% and its interest-rate sensitivity from -2 to +5. The sub-fund is a feeder fund for the French mutual fund CPR Croissance Réactive.

Documents

LanguageDocumentsTypeClosing Date
PT
PDF
17/06/2026
EN
PDF
31/07/2025
PDF
01/10/2026
PDF
31/01/2026
Prices expressed in a currency other than the base currency of the portfolio are available for information purposes only. Nothing contained in this site constitutes a solicitation or offer by any member of CPR Asset Management to provide any investment advice or service or to purchase or sell any financial instruments. The information it contains aims to inform the subscriber by providing information on the UCITS supplemental to that appearing in the Information Memorandum. The material provided on this site is presented as of the date shown and "as is". CPR Asset Management does not expressly or impliedly warrant the accuracy of the information provided on this site and expressly disclaims any warranties of fitness of this site for any particular purpose. This material reflects the opinion of the management company at the date of printing. The material is based upon information that we consider reliable, but we do not represent it is accurate, complete, valid or timely and it should not be relied on as such for any particular purpose. Any subscription should be based solely on the Information Memorandum provided to subscribers prior to the subscription and/or available upon request.The Key investor Informations document (KIID) and the prospectus of the fund, as well as the annual and semi-annual reports are available free of charge on the website www.cpr-am.com and from the Representative or Paying Agents : Best – Banco Electrónico de Serviço Total, S.A. Pº de la Castellana 1 - Madrid 28 046